INNT - Innovate Biopharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development7,405.0774,007.9111,945.806
Selling General and Administrative10,664.9917,161.6123,470.429
Non Recurring---
Total Operating Expenses18,070.06811,169.5235,416.235
Operating Income or Loss-18,070.068-11,169.523-5,416.235
Income from Continuing Operations
Total Other Income/Expenses Net-6,092.211-436.294-203.811
Earnings Before Interest and Taxes-18,070.068-11,169.523-5,416.235
Interest Expense-6,152.043-436.294-203.905
Income Before Tax-24,162.279-11,605.817-5,620.046
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-24,162.279-11,605.817-5,620.046
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-24,162.279-11,605.817-5,620.046
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-24,162.279-11,605.817-5,620.046